Submissions from 2018
Time to cognitive worsening in patients with worsening relapsing multiple sclerosis in phase III trials, Stanley Cohan
Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)., Stanley L Cohan, Harold Moses, Jonathan Calkwood, Carlo Tornatore, Chris LaGanke, Kyle E Smoot, Venkata Meka, Macaulay Okwuokenye, Christophe Hotermans, Jason P Mendoza, Monica K Mann, and Leslie A Meltzer
The results of a 24 month controlled, prospective study of relapsing MS patients at risk for PML who switched from long term natalizumab to teriflunomide, Stanley Cohan, Kyle E Smoot, Kiren Kresa-Reahl, Chiayi Chen, and Tiffany Gervasi-Follmar
Rapid cycle implementation of a standard stroke neurological check before comprehensive stroke re-certification survey, Kailey Cox and Diane Clark
Healthcare Utilization and Cost Outcomes for a Multicenter First Seizure and New Onset Epilepsy Clinic, Emily Hudson, Alyx Lesko, Lindsay Lucas, Elizabeth Baraban, Julia Toub, Matt Evans, and Evan J Fertig
Abstract WP348: Stroke Nurse Navigator: Feasibility, Implementation and Early Impact at a Comprehensive Stroke Center, Darren T. Larsen, Kailey Cox, Natalie Swearingen, and Amit Kansara
Stroke nurse navigator: Feasibility, implementation and early impact at a Comprehensive Stroke Center, Darren T. Larsen, Kailey Cox, Natalie Swearingen, and Amit Kansara
IV thrombolytic stroke treatment in the 3-4.5 hour time window: Practice diverges from guidelines, Ted Lowenkopf, Leslie Corless, Lindsay Lucas, and Elizabeth Baraban
RNA expression differentiates large artery and cardioembolic stroke: A pilot analysis from the BASE trial, Ted J Lowenkopf
Effects of opicinumab on patient reported outcomes in participants with relapsing multiple sclerosis: A post-hoc analysis of the phase II Synergy study, Jennifer Petrillo, Stanley Cohan, Carmen Castrillo-Viguera, Ih Chang, Yihong Chai, Shih-Yen Chen, and Bing Zhu
Very early mobilization after IV alteplase does not worsen patient outcomes at 90 days, John Robison, tamela stuchiner, Diane Clark, Lindsay Lucas, and Lisa Yanase
Providence Dimethyl fumarate Registry: Year five results on discontinuation and treatment outcomes, Kyle E Smoot, Chiayi Chen, Lindsay Lucas, tamela stuchiner, Elisabeth Lucassen, Meghan C Romba, Lois Grote, and Stanley Cohan
Utilization, safety and tolerability of ocrelizumab: Year 1 Data from the Providence Ocreclizumab Registry, Kyle E Smoot, Chiayi Chen, tamela stuchiner, Lois Grote, Lindsay Lucas, and Stanley Cohan
Three-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center., Kyle E Smoot, Kateri Spinelli, Tamela Stuchiner, Lindsay Lucas, Chiayi Chen, Lois Grote, Elizabeth Baraban, Kiren Kresa-Reahl, and Stanley Cohan
Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study., Sara Strzok, Sophie Cleanthous, Farrah Pompilus, Stefan J Cano, Patrick Marquis, Stanley Cohan, Myla D Goldman, Kiren Kresa-Reahl, Jennifer Petrillo, Carmen Castrillo-Viguera, Diego Cadavid, and Shih-Yin Chen
Impact of Comorbidity and DMT Use by DMT Group on Quality of Life in Participants in the Pacific Northwest MS Registry, tamela stuchiner, Elizabeth Baraban, Lindsay Lucas, Chiayi Chen, Lobat Hashemi, Anthony Ranno, Alden Smith, and Stanley Cohan
Oregon region Standard Stroke Neurological Assessment utilizing AACN Synergy model, Natalie Swearingen, Kailey Cox, and Diane Clark
Abstract 9: Compliance of a New Standard in Stroke Neuro Checks in a Comprehensive Stroke Center Compared to Primary Stroke Centers for IV Alteplase and Thrombectomy Patients, Natalie Swearingen, Kailey Cox, Alyx Lesko, Lindsay Lucas, and Diane Clark
Compliance of a new standard in stroke neuro checks in a comprehensive stroke center compared to primary stroke centers for IV alteplase and thrombectomy patients, Natalie Swearingen, Kailey Cox, Alyx Lesko, Lindsay Lucas, and Diane Clark
Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of multiple sclerosis in the real-world Teri-RADAR study, Robert Zivadinov, Chakkarin Burudpakdee, Niels Bergsland, Jeffrey Chavin, Karthinathan Thangavelu, Matt Mandell, and Stanley Cohan
Comparative effect of teriflunomide and dimethyl fumarate in patients with relapsing remitting MS in the real world Teri-RADAR study, Robert Zivadinov, Chakkarin Burudpakdee, Michael Dwyer, Niels Bergsland, Jeffrey Chavin, Karthinathan Thangavelu, Matt Mandel, and Stanley Cohan
Comparative effect of teriflunomide and dimethyl fumarate in patients with relapsing-remitting multiple sclerosis in the real-world Teri-RADAR study, Robert Zivadinov, Chakkarin Burudpakdee, Michael Dwyer, Niels Bergsland, Jeffrey Chavrin, Matt Mandell, and Stanley Cohan
Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS., Robert Zivadinov, Jennie Medin, Nasreen Khan, Jonathan R Korn, Niels Bergsland, Michael G Dwyer, Tanuja Chitnis, Robert T Naismith, Enrique Alvarez, Peter Kinkel, Stanley Cohan, Samuel F Hunter, Diego Silva, and Bianca Weinstock-Guttman
Submissions from 2017
Clinical outcomes for a multicenter first seizure and new onset epilespy clinic, Elizabeth Baraban, Lindsay Lucas, Evan J Fertig, and Matt Evans
In-hospital lifestyle interventions to prevent secondary stroke among at-risk patients varies by patient characteristics and over time: Analyses from a large, multi-Hospital network, Elizabeth Baraban, Lindsay Lucas, and Kateri Spinelli
In-hospital lifestyle interventions to prevent secondary stroke among at-risk patients varies by patient characteristics and over time: Analyses from a large, multi-Hospital network, Elizabeth Baraban, L Lucas, and Kateri Spinelli
Male gender predicts ultrafast administration of intravenous tissue plasminogen activator in a twenty-six hospital network, Archit Bhatt, Lindsay Lucas, and Elizabeth Baraban
Effectiveness and safety of fingolimod in patients with multiple sclerosis switched from natalizumab: Results from TRANSITION, a 2 year observational study, Helmut Butzkueven, Paul S. Giacomini, Stanley Cohan, Tjalf Ziemssen, and B Weller
Development of a gait module to complement the 12-item patient reported Multiple Sclerosis Walking Scale, Shih-Yen Chen, Sara Strzok, Sophie Cleanthous, Farrah Pompilus, Stefan J. Cano, Patrick Marquis, Stanley Cohan, Myla Goldman, Kiren Kresa-Reahl, Jennifer Petrillo, Carmen Castrillo-Viguera, and Diego Cadavid
Patient reported outcomes measurements in manual ability for multiple sclerosis: Addressing the target issues of the ABILHAND, Shih-Yin Chen, Farrah Pompilus, Sara Strzok, Sophie Cleanthous, Stefan Cano, Patrick Marqui, Stanley Cohan, Myla Goldman, Kiren Kresa-Reahl, Jennifer Petrillo, Carmen Castrillo-Viguera, Diego Cadavid, and Michelle Mellion
Effect of very early mobilility after IV alteplase on 24 hour National Institutes of Health Stroke Scare (NIHSS), Diane Clark, tamela stuchiner, Lindsay Lucas, Lisa Yanase, and John Robison
Effect of very early mobility after IV alteplase on discharge disposition, Diane Clark, tamela stuchiner, John Robison, Lindsay Lucas, and Lisa Yanase
Patients receiving IV alteplase who mobilize earlier show no worsening in National Institutes of Health Stroke Scale (NIHSS) at 24 hours, Diane Clark, tamela stuchiner, John Robison, Lindsay Lucas, and Lisa Yanase
ElevateMS, an iPhone-based study in multiple sclerosis patients capturing longitudinal patient reported outcomes and sensor data, Stanley Cohan
Interim report on the safety and efficacy of long-term daclizumab HYP treatment for up to five years in EXTEND, Stanley Cohan
MRI outcomes in patients treated in the EXTEND open-label extension study, Stanley Cohan, Douglas Arnold, Oksana Mokliachouk, Steven Greenburg, and Sami Fam
Effect of daclizumab beta versus intramuscular interferon beta-1a on 24 week sustained disability progression using a modified multiple sclerosis functional composite, Stanley Cohan, Ludwig Kappos, Gavin Giovanni, Heinz Wiendl, Krysztov Selmaj, Eva Kubala Havrdová, John Rose, Steven Greenburg, Glenn Phillips, Wei Ma, Ping Wang, Gabriel Lima, and Guido Sabatella
Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE., Stanley Cohan, Ludwig Kappos, Gavin Giovannoni, Heinz Wiendl, Krzysztof Selmaj, Eva Kubala Havrdová, John Rose, Steven Greenberg, Glenn Phillips, Wei Ma, Ping Wang, Gabriel Lima, and Guido Sabatella
Patients experiencing homelessness have longer lengths of stay after admission for ischemic stroke or TIA, Leslie Corless, Lindsay Lucas, and Elizabeth Baraban
Monthly 3T MRI in patients switched from natalizumab to terifluomide in a controlled prospective study, Keith Edwards, Stanley Cohan, Lore Garten, James Thomas, Kyle E Smoot, Kiren Kresa-Reahl, Judy O'Connor, Tiffany Gervasi-Follmar, Chiayi Chen, and Vineetha Kamath
Biomarkers of Acute Stroke Etiology (BASE) Study Methodology., Edward C Jauch, Andrew D Barreto, Joseph P Broderick, Doug M Char, Brett L Cucchiara, Thomas G Devlin, Alison J Haddock, William J Hicks, Brian C Hiestand, Glen C Jickling, Jeff June, David S Liebeskind, Ted J Lowenkopf, Joseph B Miller, John O'Neill, Tim L Schoonover, Frank R Sharp, and W Frank Peacock
Long-term effects of daclizumab-beta in patients with relapsing multiple sclerosis in EXTEND. Interim results from treatment for up to 6 years., Ludwig Kappos, Stanley Cohan, Douglas Arnold, Randy Robinson, Becky Parks, Huaihou Chen, and Sami Fam
Interaction between Comorbidities and Use of Disease Modifying Treatment in Impact on Disability Status in a Regional Multiple Sclerosis Registry, Lindsay Lucas, tamela stuchiner, Elizabeth Baraban, Chiayi Chen, and Stanley Cohan
Interaction between co-morbidities and use of disease modifying treatment on impact in quality of life in a regional multiple sclerosis registry, tamela stuchiner, Lindsay Lucas, Elizabeth Baraban, Chiayi Chen, and Stanley Cohan
Comparing quality of life between people who use injectable disease modifying therapies and those who switch to oral therapies: A studdy from the Pacific Northwest Multiple Sclerosis (PNWMS) Registry, tamela stuchiner, Lindsay Lucas, Elizabeth Baraban, Chiayi Chen, Alden Smith, Lobat Hashemi, and Stanley Cohan
Use of medical marijuana for the relief of multiple sclerosis (MS) symptoms in a community cohort: Survey from the Pacific Northwest MS Registry, T Suchiner, Elizabeth Baraban, L Lucas, and S Cohan
Evaluation of intervention at reducing alteplase returns without compromising clinical care in acute ischemic stroke, Natalie Swearingen, Jillian Myers, Alyx Lesko, and Elizabeth Baraban
Impact of fingolimod on brain volume measurements in relapsing-remitting patients with active disease at baseline: Results from the MS-MRIUS, a longitudinal, observational, multicenter real-world outcome study, Robert Zivadinov, Tanuja Chitnis, Robert T. Naismith, Enrique Alvarez, Samuel F. Hunter, SF Kinkel, and Stanley Cohan
Submissions from 2016
Positive impact through use of Telestroke in two large Pacific Northwest networks on clinical performance, Elizabeth Baraban, L Lucas, and Alyx Lesko
Diabetes education for stroke inpatients is incomplete and differs by stroke severity, age, and substance abuse history, Elizabeth Baraban, L Lucas, and T Lowenkopf
At-risk stroke patients in need of in-hospital lifestyle interventions: Data from a multi-state health system, Elizabeth Baraban, T Stuchiner, and T Lowenkopf
Submissions from 2015
Abstract W P350: A Quality Enhancement Project to Capture Actual Weights Prior to Initiation of IV t-PA, Natalie Swearingen
Submissions from 2013
Why Registries Matter: Impact of a Comprehensive Telestroke Registry on Clinical Quality Improvement, Elizabeth Baraban, Alyx Lesko, L Corless, S Fisher, and N Okon
Previous Stroke and Carotid Stenting Predict Periprocedural Risk of Symptomatic Carotid Intervention, Elizabeth Baraban, T Stuchiner, W Williamson, D Ellis, K Zerr, and T Lowenkopf
Submissions from 2004
Cerebrovascular Risk Factors, Executive Dysfunction, and Depression in Primary Care Elders, Shelley Schoepflin Sanders, Jeffrey Lyness, and Shirley Eberly
